Pro Medicus Ltd (PME) - Net Assets

Latest as of December 2025: AU$388.93 Million AUD ≈ $275.19 Million USD

Based on the latest financial reports, Pro Medicus Ltd (PME) has net assets worth AU$388.93 Million AUD (≈ $275.19 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$533.91 Million ≈ $377.78 Million USD) and total liabilities (AU$144.99 Million ≈ $102.59 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Pro Medicus Ltd (PME) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$388.93 Million
% of Total Assets 72.84%
Annual Growth Rate 18.08%
5-Year Change 214.59%
10-Year Change 838.33%
Growth Volatility 17.74

Pro Medicus Ltd - Net Assets Trend (1999–2025)

This chart illustrates how Pro Medicus Ltd's net assets have evolved over time, based on quarterly financial data. See Pro Medicus Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Pro Medicus Ltd (1999–2025)

The table below shows the annual net assets of Pro Medicus Ltd from 1999 to 2025. For live valuation and market cap data, see market value of Pro Medicus Ltd.

Year Net Assets Change
2025-06-30 AU$256.96 Million
≈ $181.82 Million		 +36.88%
2024-06-30 AU$187.73 Million
≈ $132.83 Million		 +35.27%
2023-06-30 AU$138.78 Million
≈ $98.19 Million		 +36.41%
2022-06-30 AU$101.73 Million
≈ $71.98 Million		 +24.54%
2021-06-30 AU$81.68 Million
≈ $57.80 Million		 +35.72%
2020-06-30 AU$60.18 Million
≈ $42.58 Million		 +22.10%
2019-06-30 AU$49.29 Million
≈ $34.87 Million		 +40.55%
2018-06-30 AU$35.07 Million
≈ $24.81 Million		 +0.67%
2017-06-30 AU$34.83 Million
≈ $24.65 Million		 +27.20%
2016-06-30 AU$27.39 Million
≈ $19.38 Million		 +24.83%
2015-06-30 AU$21.94 Million
≈ $15.52 Million		 +5.94%
2014-06-30 AU$20.71 Million
≈ $14.65 Million		 -1.20%
2013-06-30 AU$20.96 Million
≈ $14.83 Million		 +30.98%
2012-06-30 AU$16.00 Million
≈ $11.32 Million		 +5.29%
2011-06-30 AU$15.20 Million
≈ $10.75 Million		 -9.67%
2010-06-30 AU$16.82 Million
≈ $11.90 Million		 +4.22%
2009-06-30 AU$16.14 Million
≈ $11.42 Million		 +2.53%
2008-06-30 AU$15.74 Million
≈ $11.14 Million		 +10.43%
2007-06-30 AU$14.26 Million
≈ $10.09 Million		 +7.96%
2006-06-30 AU$13.21 Million
≈ $9.34 Million		 +3.03%
2005-06-30 AU$12.82 Million
≈ $9.07 Million		 +15.74%
2004-06-30 AU$11.07 Million
≈ $7.84 Million		 +3.04%
2003-06-30 AU$10.75 Million
≈ $7.60 Million		 +44.23%
2002-06-30 AU$7.45 Million
≈ $5.27 Million		 +44.98%
2001-06-30 AU$5.14 Million
≈ $3.64 Million		 +55.57%
2000-06-30 AU$3.30 Million
≈ $2.34 Million		 -3.11%
1999-06-30 AU$3.41 Million
≈ $2.41 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Pro Medicus Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6940.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Retained Earnings AU$239.46 Million 93.19%
Common Stock AU$34.73 Million 13.52%
Other Comprehensive Income AU$-17.23 Million -6.71%
Total Equity AU$256.96 Million 100.00%

Pro Medicus Ltd Competitors by Market Cap

The table below lists competitors of Pro Medicus Ltd ranked by their market capitalization.

Company Market Cap
Krung Thai Bank Public Company Limited
F:NVPB
 $11.81 Billion
Unisplendour Corp Ltd
SHE:000938
 $11.81 Billion
Turkiye Garanti Bankasi A.S.
IS:GARAN
 $11.84 Billion
Corebridge Financial Inc.
NYSE:CRBG
 $11.85 Billion
Littelfuse Inc
NASDAQ:LFUS
 $11.78 Billion
GJENSIDIGE FORSI.UNSP.ADR
F:XGJ0
 $11.78 Billion
B3 S.A. UNSP.ADR/1
F:YBV0
 $11.78 Billion
Alchip Technologies Ltd
TW:3661
 $11.77 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pro Medicus Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 187,728,000 to 256,963,000, a change of 69,235,000 (36.9%).
  • Net income of 115,217,000 contributed positively to equity growth.
  • Dividend payments of 49,114,000 reduced retained earnings.
  • Share repurchases of 7,853,000 reduced equity.
  • Other comprehensive income decreased equity by 7,953,000.
  • Other factors increased equity by 18,938,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$115.22 Million +44.84%
Dividends Paid AU$49.11 Million -19.11%
Share Repurchases AU$7.85 Million -3.06%
Other Comprehensive Income AU$-7.95 Million -3.09%
Other Changes AU$18.94 Million +7.37%
Total Change AU$- 36.88%

Book Value vs Market Value Analysis

This analysis compares Pro Medicus Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 65.01x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 4681.23x to 65.01x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-06-30 AU$0.03 AU$159.63 x
2000-06-30 AU$0.03 AU$159.63 x
2001-06-30 AU$0.05 AU$159.63 x
2002-06-30 AU$0.07 AU$159.63 x
2003-06-30 AU$0.11 AU$159.63 x
2004-06-30 AU$0.11 AU$159.63 x
2005-06-30 AU$0.13 AU$159.63 x
2006-06-30 AU$0.13 AU$159.63 x
2007-06-30 AU$0.14 AU$159.63 x
2008-06-30 AU$0.16 AU$159.63 x
2009-06-30 AU$0.16 AU$159.63 x
2010-06-30 AU$0.17 AU$159.63 x
2011-06-30 AU$0.15 AU$159.63 x
2012-06-30 AU$0.16 AU$159.63 x
2013-06-30 AU$0.21 AU$159.63 x
2014-06-30 AU$0.21 AU$159.63 x
2015-06-30 AU$0.21 AU$159.63 x
2016-06-30 AU$0.26 AU$159.63 x
2017-06-30 AU$0.33 AU$159.63 x
2018-06-30 AU$0.34 AU$159.63 x
2019-06-30 AU$0.47 AU$159.63 x
2020-06-30 AU$0.58 AU$159.63 x
2021-06-30 AU$0.78 AU$159.63 x
2022-06-30 AU$0.97 AU$159.63 x
2023-06-30 AU$1.33 AU$159.63 x
2024-06-30 AU$1.79 AU$159.63 x
2025-06-30 AU$2.46 AU$159.63 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pro Medicus Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 44.84%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 54.12%
  • • Asset Turnover: 0.63x
  • • Equity Multiplier: 1.32x
  • Recent ROE (44.84%) is above the historical average (38.25%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 36.42% 0.00% 0.00x 1.52x AU$901.00K
2000 99.61% 36.16% 1.31x 2.10x AU$2.96 Million
2001 79.49% 40.91% 1.07x 1.82x AU$3.57 Million
2002 64.57% 47.38% 0.89x 1.53x AU$4.07 Million
2003 42.30% 49.96% 0.73x 1.17x AU$3.47 Million
2004 32.30% 45.28% 0.60x 1.18x AU$2.47 Million
2005 42.85% 53.45% 0.67x 1.20x AU$4.21 Million
2006 46.30% 54.12% 0.73x 1.17x AU$4.79 Million
2007 49.46% 56.24% 0.71x 1.23x AU$5.63 Million
2008 50.39% 86.63% 0.47x 1.24x AU$6.36 Million
2009 35.20% 57.17% 0.45x 1.36x AU$4.07 Million
2010 23.30% 20.42% 0.80x 1.43x AU$2.24 Million
2011 3.31% 3.60% 0.60x 1.52x AU$-1.02 Million
2012 11.19% 15.83% 0.49x 1.45x AU$190.80K
2013 24.48% 46.00% 0.38x 1.40x AU$3.04 Million
2014 7.29% 10.58% 0.49x 1.41x AU$-561.70K
2015 14.66% 18.39% 0.58x 1.37x AU$1.02 Million
2016 23.25% 23.14% 0.70x 1.44x AU$3.63 Million
2017 26.76% 29.50% 0.67x 1.36x AU$5.84 Million
2018 28.42% 27.74% 0.59x 1.74x AU$6.46 Million
2019 38.80% 38.17% 0.59x 1.71x AU$14.20 Million
2020 38.34% 40.61% 0.59x 1.59x AU$17.06 Million
2021 37.77% 45.45% 0.54x 1.54x AU$22.68 Million
2022 43.69% 47.55% 0.60x 1.54x AU$34.27 Million
2023 43.70% 48.56% 0.62x 1.46x AU$46.77 Million
2024 44.10% 51.29% 0.63x 1.37x AU$64.02 Million
2025 44.84% 54.12% 0.63x 1.32x AU$89.52 Million

Industry Comparison

This section compares Pro Medicus Ltd's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $25,787,494
  • Average return on equity (ROE) among peers: -30.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Pro Medicus Ltd (PME) AU$388.93 Million 36.42% 0.37x $11.80 Billion
Adheris Health Limited (AHE) $48.97 Million -28.49% 0.65x $132.19
Alcidion Group Ltd (ALC) $90.17 Million -4.01% 0.34x $99.77 Million
ARTRYA Ltd (AYA) $51.05 Million -7.99% 0.02x $528.23 Million
Beamtree Holdings Ltd (BMT) $48.58 Million -9.16% 0.32x $19.13 Million
Cogstate Ltd (CGS) $3.98 Million 28.96% 0.31x $303.46 Million
Careteq Ltd (CTQ) $1.52 Million -4.75% 2.91x $6.42 Million
Doctor Care Anywhere Group Plc (DOC) $-645.00K 0.00% 0.00x $33.73 Million
Echoiq Ltd (EIQ) $-464.69K 0.00% 0.00x $624.25 Million
Emyria Ltd (EMD) $3.78 Million -138.47% 0.34x $26.82 Million
Enlitic Inc (ENL) $10.94 Million -142.15% 0.06x $4.72 Million

About Pro Medicus Ltd

AU:PME Australia Health Information Services
Market Cap
$11.80 Billion
AU$16.68 Billion AUD
Market Cap Rank
#1986 Global
#41 in Australia
Share Price
AU$159.63
Change (1 day)
-0.28%
52-Week Range
AU$108.15 - AU$330.48
All Time High
AU$330.48
Categories
Companies in Australia Health Information Services Technology
About

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiol… Read more